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Background
PION (Pigeon homologue protein), located on chromo-
some 7q11.23, encodes gSAP (gamma-secretase activat-
ing protein), which is cleaved to form a 16 kDa C-
terminal fragment (gSAP-16K) that interacts with
gamma-secretase to facilitate the cleavage of amyloid
precursor protein-beta-C-terminal fragment (APP-beta-
CTF), releasing the neurotoxic peptide A-beta [He G, et
al, Nature 2010]. The study by He G, el al. also demon-
strated that partial siRNA-mediated inhibition of gSAP
expression in N2a cells reduces A-beta production, sug-
gesting that gSAP-16K modulates APP-beta-CTF clea-
vage in a dose-dependent manner. Taken together, these
observations suggest that levels of PION gene expression
in human brain may also affect levels of A-beta produc-
tion and thereby influence the risk of developing Alzhei-
mer’s disease. The goal of the present study is to
quantify variation of PION mRNA expression in human
prefrontal cortex and identify haplotypes and/or combi-
nations of genotypes that predict high- or low-levels of
mRNA expression.
Methods
Sixty-four independent frozen sections of prefrontal cor-
tex (Han Chinese autopsy samples; Brodmann area 46)
were obtained from the China Brain Bank Center
(Wuhan, China). Genomic DNA and total RNA were
isolated using standard techniques. A common SNP,
rs2037753 (heterozygosity = 0.422), located within exon
16 of PION mRNA was chosen as a molecular marker
to distinguish mRNAs derived from each autosomal
allele. SNaPShot©-based AEI assays were carried out as
previously described [Lim JE, Molecular Psychiatry,
2007]. Analysis of population distributions of log2AEI
ratios was carried out using a mathematical model
developed in-house. Levels of PION mRNA relative to
mRNA encoding the house-keeping gene GAPDH were
quantified by real-time PCR (calculated as ΔCt). Geno-
mewide genotyping of all the above samples was carried
out using HumanOmni1-Qad arras (Illumina) arrays.
SNPs with genotypes that correlate with relative expres-
sion of PION mRNA were identified by linear regression
analysis for SNPs within a 205,650 base pair region of
chromosome 7 centered on PION.
Results
We observed robust allele-specific expression of PION
mRNA in approximately 24 out of 34 samples heterozy-
gous for the marker SNP. Mathematical modeling of the
log2AEI population distributions predicted that PION
mRNA expression is controlled by three cis-acting regu-
latory elements, one of which is in partial linkage dise-
quilibrium with the marker SNP. Scanning SNPs in the
region of the PION gene for correlations with mRNA
expression revealed a single SNP, rs10271991 (located in
intron 22), that is highly correlated with mRNA expres-
sion (r2 = 23.5; P =0.0001). Comparison between a
model that includes rs10271991 (Major allele frequency
= 0.51; D’ with marker SNP = 0.8) and experimentally
determined log2AEI distributions yielded excellent
agreement (r2 = 0.96). According to this model, the
remaining two variants that control expression of PION
mRNA are both predicted to have major allele frequen-
cies of approximately 0.8 and to be unlinked to the mar-
ker SNP (i.e., D’ = 0).
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Conclusions
We have used real-time PCR-based measurements of
relative mRNA expression in human prefrontal cortex
and genotyping to identify a SNP within the PION gene
that correlates with mRNA expression. Our modeling of
population distributions of log2AEI ratios predicts that
PION mRNA expression is controlled by a variant
linked to this SNP plus two additional variants that
remain to be identified.
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